MA47607A - Synthèse à grande échelle d'arn messager - Google Patents
Synthèse à grande échelle d'arn messagerInfo
- Publication number
- MA47607A MA47607A MA047607A MA47607A MA47607A MA 47607 A MA47607 A MA 47607A MA 047607 A MA047607 A MA 047607A MA 47607 A MA47607 A MA 47607A MA 47607 A MA47607 A MA 47607A
- Authority
- MA
- Morocco
- Prior art keywords
- arn
- messenger
- scale synthesis
- synthesis
- scale
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1068—Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44773—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis
- G01N27/44778—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis on a common gel carrier, i.e. 2D gel electrophoresis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Electrochemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762464043P | 2017-02-27 | 2017-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47607A true MA47607A (fr) | 2020-01-01 |
Family
ID=61800667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA047607A MA47607A (fr) | 2017-02-27 | 2018-02-27 | Synthèse à grande échelle d'arn messager |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11560562B2 (fr) |
| EP (2) | EP4105326A1 (fr) |
| AU (1) | AU2018224325B2 (fr) |
| CA (1) | CA3053814A1 (fr) |
| DK (1) | DK3585886T3 (fr) |
| IL (2) | IL310939A (fr) |
| MA (1) | MA47607A (fr) |
| WO (1) | WO2018157153A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3354644A1 (fr) | 2011-06-08 | 2018-08-01 | Translate Bio, Inc. | Lipides clivables |
| CA3079428A1 (fr) | 2017-11-22 | 2019-05-31 | Modernatx, Inc. | Polynucleotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'uree |
| CA3165388A1 (fr) | 2019-12-20 | 2021-06-24 | Translate Bio, Inc. | Procede ameliore de preparation de nanoparticules lipidiques chargees d'arnm |
| KR20220142432A (ko) | 2019-12-20 | 2022-10-21 | 트랜슬레이트 바이오 인코포레이티드 | 메신저 rna의 직장 전달 |
| US20210324369A1 (en) | 2020-02-10 | 2021-10-21 | Translate Bio, Inc. | Methods and compositions for messenger rna purification |
| JP2023513836A (ja) | 2020-02-18 | 2023-04-03 | トランスレイト バイオ， インコーポレイテッド | メッセンジャーｒｎａのインビトロ転写プロセスの改善 |
| WO2021173840A1 (fr) | 2020-02-25 | 2021-09-02 | Translate Bio, Inc. | Procédés améliorés de préparation de nanoparticules lipidiques chargées d'arnm |
| WO2021226463A1 (fr) | 2020-05-07 | 2021-11-11 | Translate Bio, Inc. | Composition et méthodes de traitement d'une dyskinésie ciliaire primitive |
| KR20230008801A (ko) | 2020-05-07 | 2023-01-16 | 트랜슬레이트 바이오 인코포레이티드 | Sars-cov-2 항원을 암호화하는 최적화된 뉴클레오티드 서열 |
| EP4149425A1 (fr) | 2020-05-15 | 2023-03-22 | Translate Bio, Inc. | Formulations de nanoparticules lipidiques pour l'administration d'arnm |
| CA3194863A1 (fr) | 2020-10-06 | 2022-04-14 | Shrirang KARVE | Procede ameliore et formulation de nanoparticules lipidiques |
| WO2022081548A1 (fr) | 2020-10-12 | 2022-04-21 | Translate Bio, Inc. | Procédé amélioré de préparation de nanoparticules lipidiques à base de glace |
| AU2021361986A1 (en) | 2020-10-12 | 2023-06-15 | Translate Bio, Inc. | Improved process of preparing mrna-loaded lipid nanoparticles |
| EP4229191A1 (fr) * | 2020-10-15 | 2023-08-23 | Translate Bio, Inc. | Synthèse à grande échelle d'arn messager |
| WO2022099003A1 (fr) * | 2020-11-06 | 2022-05-12 | Sanofi | Nanoparticules lipidiques pour l'administration de vaccins à arnm |
| WO2022204549A1 (fr) | 2021-03-25 | 2022-09-29 | Translate Bio, Inc. | Séquences nucléotidiques optimisées codant pour le domaine extracellulaire de la protéine ace2 humaine ou une portion de celle-ci |
| CA3215606A1 (fr) | 2021-04-19 | 2022-10-27 | Shrirang KARVE | Compositions ameliorees pour l'administration d'arnm |
| CN117881395A (zh) | 2021-07-01 | 2024-04-12 | 翻译生物公司 | 用于递送mRNA的组合物 |
| WO2023086893A1 (fr) | 2021-11-10 | 2023-05-19 | Translate Bio, Inc. | Composition et méthodes de traitement de la dyskinésie ciliaire primitive |
| US20240043892A1 (en) * | 2022-07-01 | 2024-02-08 | Arcturus Therapeutics, Inc. | Methods for in vitro transcription |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3611266T1 (sl) | 2005-08-23 | 2023-02-28 | The Trustees Of The University Of Pennsylvania | Modificirani nukleozidi, ki vsebujejo RNA, in postopki za njihovo uporabo |
| WO2009030254A1 (fr) | 2007-09-04 | 2009-03-12 | Curevac Gmbh | Complexes d'arn et de peptides cationiques pour transfection et immunostimulation |
| AU2010278309B2 (en) | 2009-07-31 | 2013-10-31 | Ethris Gmbh | RNA with a combination of unmodified and modified nucleotides for protein expression |
| US8326547B2 (en) | 2009-10-07 | 2012-12-04 | Nanjingjinsirui Science & Technology Biology Corp. | Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm |
| US20110244026A1 (en) | 2009-12-01 | 2011-10-06 | Braydon Charles Guild | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
| WO2012075040A2 (fr) | 2010-11-30 | 2012-06-07 | Shire Human Genetic Therapies, Inc. | Arnm pour l'utilisation dans le traitement de maladies génétiques humaines |
| AU2012267531B2 (en) | 2011-06-08 | 2017-06-22 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
| AU2014239250A1 (en) | 2013-03-14 | 2015-08-27 | Shire Human Genetic Therapies, Inc. | Quantitative assessment for cap efficiency of messenger RNA |
| EP3467108B1 (fr) | 2013-03-14 | 2024-05-22 | Translate Bio, Inc. | Procédés de purification d'arn messager |
| EA201691696A1 (ru) | 2014-04-25 | 2017-03-31 | Шир Хьюман Дженетик Терапис, Инк. | Способы очистки матричной рнк |
| MX2016016170A (es) * | 2014-06-10 | 2017-03-28 | Curevac Ag | Metodos y medios para aumentar la produccion de arn. |
| JP6895892B2 (ja) * | 2015-03-19 | 2021-06-30 | トランスレイト バイオ， インコーポレイテッド | ポンペ病のｍＲＮＡ治療 |
| WO2016180430A1 (fr) * | 2015-05-08 | 2016-11-17 | Curevac Ag | Procédé de production d'arn |
-
2018
- 2018-02-27 EP EP22169158.7A patent/EP4105326A1/fr active Pending
- 2018-02-27 US US15/907,163 patent/US11560562B2/en active Active
- 2018-02-27 IL IL310939A patent/IL310939A/en unknown
- 2018-02-27 AU AU2018224325A patent/AU2018224325B2/en active Active
- 2018-02-27 DK DK18713747.6T patent/DK3585886T3/da active
- 2018-02-27 IL IL268892A patent/IL268892B1/en unknown
- 2018-02-27 EP EP18713747.6A patent/EP3585886B1/fr active Active
- 2018-02-27 CA CA3053814A patent/CA3053814A1/fr active Pending
- 2018-02-27 WO PCT/US2018/020008 patent/WO2018157153A1/fr unknown
- 2018-02-27 MA MA047607A patent/MA47607A/fr unknown
-
2022
- 2022-12-14 US US18/065,952 patent/US20240018514A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3053814A1 (fr) | 2018-08-30 |
| WO2018157153A1 (fr) | 2018-08-30 |
| AU2018224325B2 (en) | 2024-05-02 |
| EP3585886B1 (fr) | 2023-11-22 |
| DK3585886T3 (da) | 2024-02-19 |
| EP4105326A1 (fr) | 2022-12-21 |
| IL310939A (en) | 2024-04-01 |
| US20240018514A1 (en) | 2024-01-18 |
| AU2018224325A1 (en) | 2019-09-12 |
| US20180258423A1 (en) | 2018-09-13 |
| IL268892B1 (en) | 2024-03-01 |
| IL268892A (en) | 2019-10-31 |
| EP3585886A1 (fr) | 2020-01-01 |
| US11560562B2 (en) | 2023-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA47607A (fr) | Synthèse à grande échelle d'arn messager | |
| MA49421A (fr) | Formulations d'arn | |
| EP3532858A4 (fr) | Estimation de direction d'arrivée | |
| IT201700062337A1 (it) | Occhiali con dispositivi auricolari | |
| MA46761A (fr) | Administration sous-cutanée d'arn messager | |
| MA42690A (fr) | Micropropagation d'un dattier abada | |
| IT201700074911A1 (it) | Procedimento per la produzione di olefine da alcoli | |
| MA53238A (fr) | Formules d'ag10 | |
| IT201700035964A1 (it) | “divisorio per boiserie” | |
| UA41790S (uk) | Блуза | |
| IT201900025780A1 (it) | Dispositivo per la produzione di idrogeno | |
| IT201700112534A1 (it) | Capo d'abbigliamento | |
| IT201700088590A1 (it) | Struttura di occhiali. | |
| IT201700090331A1 (it) | "lopemide" | |
| IT201700071679A1 (it) | Remembebe' | |
| AU2016904636A0 (en) | Direction of Arrival Estimation | |
| AU2016904419A0 (en) | Direction of Arrival Estimation | |
| IT201700110269U1 (it) | “Forno Bellavista” | |
| IT201700123558A1 (it) | Processo per la sintesi di 2-benzidril-3 chinuclidinone | |
| UA34895S (uk) | Інтер'єр ресторану | |
| IT201700034613A1 (it) | Struttura di teleferica perfezionata | |
| EP3523655A4 (fr) | Dosages de point d'intervention | |
| UA36364S (uk) | Комплект етикеток | |
| UA36348S (uk) | Комплект етикеток | |
| IT201700068126A1 (it) | Struttura di filtropressa |